UK’s Most Affordable Clinician-led Weight Loss Treatment






Foundayo is a prescription-only medicine containing orforglipron, manufactured by Eli Lilly, the pharmaceutical company behind Mounjaro. Taken once daily, it helps eligible adults lose weight and maintain their results over time.
Foundayo is now available. Start an online consultation to see if this once-daily treatment is right for you.
New to Foundayo? Treatment starts at 0.8mg.
Foundayo is a once-daily oral weight loss medicine available through Online Weight Loss Clinic, subject to a medical assessment and clinician approval. Complete our quick online consultation to check your eligibility. If approved, you can proceed with your prescription and order Foundayo online.
Clinical studies show that Orforglipron achieved an average weight loss of 12.4% over 72 weeks, compared with 2.1% with placebo.

If you are using Mounjaro, Wegovy injection or Wegovy pill, you may be able to move to Foundayo. Starting at 0.8 mg is not always necessary, as the dose selected can vary according to your existing medicine and current strength.
A clinician should oversee any change in treatment. The doses below are not intended for self-directed switching.
Yes. Moving from Mounjaro to Foundayo may be possible. The Foundayo dose selected can vary depending on your current weekly Mounjaro dose.
| Current Mounjaro dose | Foundayo dose |
|---|---|
| 2.5 mg weekly | 0.8 mg daily |
| 5 mg weekly | 2.5 mg daily |
| 7.5 mg weekly | 2.5 mg daily |
| 10 mg weekly | 5.5 mg daily |
| 12.5 mg weekly | 9 mg daily |
| 15 mg weekly | 9 mg daily |
Yes. It may be possible to move from a weekly Wegovy injection to once-daily Foundayo. Your existing Wegovy dose can help determine which Foundayo strength is appropriate when changing treatment.
| Current Wegovy injection dose | Foundayo dose |
|---|---|
| 0.25 mg weekly | 0.8 mg daily |
| 0.5 mg weekly | 0.8 mg daily |
| 1 mg weekly | 2.5 mg daily |
| 1.7 mg weekly | 5.5 mg daily |
| 2.4 mg weekly | 9 mg daily |
| 7.2 mg weekly | 9 mg daily |
As an oral medicine, Foundayo may suit people looking to move away from a weekly injectable treatment.
Yes. A change from Wegovy pill to Foundayo may be an option. The Foundayo strength selected can vary according to the daily Wegovy pill dose you currently use.
| Current Wegovy pill dose | Foundayo dose |
|---|---|
| 1.5 mg daily | 0.8 mg daily |
| 4 mg daily | 0.8 mg daily |
| 9 mg daily | 2.5 mg daily |
| 25 mg daily | 5.5 mg daily |
Foundayo also offers greater flexibility around meals, as the tablet can be taken on a full or empty stomach without specific food or water restrictions.
Please note: Switching requirements differ between individuals. Do not change your medicine or dose without advice from a clinician.

Clinical studies show that Orforglipron can support significant weight loss when used alongside a reduced-calorie diet and increased physical activity. In a 72-week clinical trial, participants taking Orforglipron achieved an average weight loss of 12.4%, demonstrating its potential as an effective option for weight management.
In comparison, participants receiving placebo experienced an average weight loss of 2.1% over the same period. These results highlight the difference in weight-loss outcomes observed between Orforglipron and placebo during the study period.
Foundayo is now available in the UK as a once-daily weight loss treatment. Eligible patients can access this oral GLP-1 medication through our service following a clinical assessment and approval process.

The Foundayo pill contains orforglipron, a small-molecule, non-peptide GLP-1 receptor agonist used for weight management. Its oral formulation means it can be taken without the fasting requirements associated with some other oral GLP-1 medicines.
The Foundayo tablet is taken once daily and swallowed whole. It can be taken at any time of day, with or without food, allowing treatment to fit more easily into your usual routine.
The active ingredient, orforglipron, activates GLP-1 receptors that play a role in appetite, digestion and blood glucose control. By acting on these pathways, Foundayo may help you eat less and manage your weight over time.
The Foundayo tablet works by:
Together, these effects can support sustained weight management when Foundayo is combined with a reduced-calorie diet and increased physical activity.
Foundayo may be considered for people aged 18 and over who meet one of the following BMI criteria:
Treatment should be used alongside a reduced-calorie diet and increased physical activity. The suitability of the Foundayo pill will be assessed individually by a clinician before it is prescribed.
The Foundayo pill was studied in the Phase 3 ATTAIN-1 trial, involving 3,127 adults with obesity or overweight and at least one related health condition, without diabetes. Participants took orforglipron or placebo once daily for 72 weeks alongside dietary changes and increased physical activity.
Using the efficacy estimand, participants receiving the highest 36 mg investigational dose achieved an average body weight reduction of 12.4% after 72 weeks. At this dose:
The study also reported improvements in cardiometabolic measures, including waist circumference, systolic blood pressure, triglycerides and non-HDL cholesterol.
Important: These results are based on the efficacy estimand from the ATTAIN-1 trial and do not indicate how much weight an individual will lose. Results with orforglipron vary depending on individual factors and response to treatment.
There are six Foundayo dosage strengths, starting at 0.8 mg once daily. The dose is increased gradually, with each step usually lasting at least 30 days to give your body time to adapt.
You may not need to reach the maximum Foundayo dosage. Our clinician will consider how you are responding and tolerating treatment before recommending any increase. Always follow your prescribed dosing plan and only change your dose when advised by our clinician.
Take Foundayo once daily at a time that suits your routine, with or without food. Swallow the tablet whole and do not crush, split or chew it. Do not take more than one tablet within 24 hours. There is no need to fast or plan your dose around meals. Taking Foundayo at a similar time each day may make it easier to remember. Follow the dosing instructions provided by our clinician and the patient information leaflet.
If you forget your dose, take the tablet when you remember, provided you have not already taken Foundayo that day. Never take two tablets at once to make up for a missed dose.
Contact our clinician promptly if you take more Foundayo pill than prescribed. Taking too much may increase the likelihood of side effects, including nausea and vomiting.
Talk to our clinician before ending treatment. The effects on appetite may reduce after stopping Foundayo, meaning hunger can increase and maintaining weight loss may become more difficult. For people with type 2 diabetes, stopping treatment may also influence blood glucose levels. Our clinician can advise on the appropriate next steps for your individual circumstances.
The Foundayo tablet may be used for long-term weight management while treatment remains appropriate, effective and well tolerated. Participants in the ATTAIN-1 trial received orforglipron for 72 weeks. Continued treatment will depend on your progress, response and ongoing clinical reviews.
As with other prescription medicines, Foundayo side effects are possible, but they do not affect everyone. Gastrointestinal effects, including nausea, diarrhoea and vomiting, are reported most frequently and may be more noticeable when beginning orforglipron treatment.
Very common effects include:
Common effects include:
Uncommon effects include:
Seek urgent medical attention if you develop severe and persistent pain in your abdomen or back, as this may be a sign of acute pancreatitis.
Serious Foundayo side effects may occur, including reactions for which the frequency is not yet known. These can include sudden changes in vision, bowel obstruction, severe constipation, serious allergic reactions and kidney problems. Seek prompt medical help for symptoms such as severe abdominal pain, ongoing vomiting, significant dehydration, difficulty breathing, or swelling of the face or throat. For comprehensive safety information and all reported reactions, refer to the Foundayo patient information leaflet .
The duration of Foundayo side effects differs between individuals. Digestive symptoms such as nausea, diarrhoea and vomiting may be more noticeable when you first start orforglipron or move to a higher dose, and may ease as your body adjusts. Contact our clinical team if symptoms persist, worsen or begin to interfere with your everyday activities.
Simple changes to your diet and routine may help with some digestive symptoms:
Check with a healthcare professional before taking other medicines for side effects to ensure they are appropriate to use with the Foundayo tablet.
Certain Foundayo side effects need prompt medical assessment. Seek medical advice if you develop signs of a potentially serious reaction, such as:
If you are due to have surgery or another procedure requiring anaesthesia or deep sedation, make sure your healthcare professional knows that you are taking Foundayo.
Understanding Foundayo warnings can help ensure treatment is used safely. Before prescribing, our clinician will consider your medical history, existing conditions and any factors that could affect whether the medicine is appropriate for you. Do not take Foundayo tablets if you have an allergy to orforglipron or any other ingredient in the medicine. Before treatment, let our clinician know if you have or have previously experienced:
Do not use the Foundayo pill during pregnancy or while breastfeeding. If you plan to become pregnant, discuss this with our clinician, as treatment should be discontinued at least three weeks before trying to conceive.
Before taking the Foundayo pill, tell our clinician about any prescription medicines, over-the-counter treatments, supplements or herbal products you use. Some treatments can change the amount of orforglipron in your body, while Foundayo tablets may affect how certain other medicines work. Medicines that can increase orforglipron levels include:
Medicines that can decrease orforglipron levels include:
If you take medicines such as simvastatin, rosuvastatin or topotecan, our clinician may consider closer monitoring or changes to your treatment where appropriate.
The orforglipron pill may reduce the effectiveness of some oral hormonal contraceptives. If you take the contraceptive pill, let our clinician know before starting treatment.You may be advised to use an additional barrier method, such as condoms, or switch to a non-oral contraceptive. This may be needed for 30 days after starting the Foundayo tablet and for 30 days after each dose increase.
Yes, Foundayo is now available on private prescription in the UK. Online Weight Loss Clinic can provide treatment to eligible adults following a clinical review to confirm suitability for treatment. NHS access remains subject to the NICE evaluation process and subsequent commissioning decisions.
Please note: Only obtain Foundayo tablets from regulated healthcare providers and registered pharmacies.
Several prescription weight management medicines may be considered as Foundayo alternatives in the UK. Options differ in how they are taken, their active ingredients, dosing frequency and the receptors they target. Choosing an appropriate treatment will depend on factors such as your medical history, individual needs and weight management goals.
Important: *These weight loss figures come from separate clinical trials involving different participants, doses and study designs. They should not be used to directly compare the effectiveness of these medicines, and individual outcomes can vary.
Our clinician will consider your medical history, treatment needs and individual circumstances when assessing which weight management option may be suitable for you.
A Foundayo vs Wegovy pill comparison involves two once-daily oral GLP-1 weight management treatments with different active ingredients. Foundayo pill contains orforglipron, whereas the Wegovy pill contains semaglutide.
Their dosing instructions also differ. Foundayo can be taken at any time of day without specific food or water restrictions. The Wegovy pill is taken on an empty stomach with a limited amount of water, followed by a 30-minute period before having food, drinks or other oral medicines.
When looking at Foundayo vs Mounjaro, the treatments differ in their active ingredients, format and receptor activity. Foundayo contains orforglipron and is taken as a daily tablet, while Mounjaro contains tirzepatide and is administered as a weekly injection.
Foundayo acts on GLP-1 receptors, whereas Mounjaro targets both GIP and GLP-1 receptors. Both can support weight management through effects on appetite and fullness. Which option is appropriate for you will depend on your health, medical history and individual clinical assessment.
The Foundayo vs Wegovy comparison shows several differences in how these treatments are formulated and taken. Foundayo tablet contains orforglipron as a once-daily tablet, whereas Wegovy contains semaglutide and is administered by injection once a week.
Both are GLP-1 receptor agonists that act on pathways involved in appetite and fullness. However, their treatment formats differ, with Foundayo taken orally and Wegovy delivered by injection.
Foundayo is now available through Online Weight Loss Clinic. Our clinician-led service includes:
Foundayo will only be prescribed if our clinician determines that treatment is safe and appropriate for your individual circumstances.
Let’s talk about how we can work together to make healthcare work for all of us.